New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - antithymocyte immunoglobulin 25mg (rabbit) - powder for infusion - 25 mg - active: antithymocyte immunoglobulin 25mg (rabbit) excipient: glycine mannitol sodium chloride - thymoglobuline® (rabbit anti - human thymocyte immunoglobulin) is indicated for the prophylaxis of graft rejection in renal transplantation; treatment of steroid - resistant or moderate to severe renal transplant rejection and in the prophylaxis of graft rejection in heart transplantation.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (sodium cation - unii:lyr4m0nh37, gluconic acid - unii:r4r8j0q44b), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - sodium chloride 0.53 g in 100 ml - this solution is indicated for use in adults as a source of electrolytes and water for hydration, and as an alkalinizing agent. contraindications: none known. accurate clinical and laboratory estimation of fluid and electrolyte balance in order to access benefit/risk ratio are essential prior to administration of this solution (see warnings and precautions ).

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 0.6 g in 100 ml

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - dextrose (unii: iy9xdz35w2) (dextrose - unii:iy9xdz35w2) - dextrose 5 g in 100 ml

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - sodium chloride 0.9 g in 100 ml - potassium chloride in 0.9% sodium chloride injection is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. potassium chloride in 0.9% sodium chloride injection is contraindicated in clinical conditions where additives of sodium, potassium or chloride could be clinically detrimental.

United States - English - NLM (National Library of Medicine)

american regent, inc. - sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc) - sodium acetate anhydrous 135 mg in 1 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

biotronik australia pty ltd - 47270 - biventricular pacemaker/defibrillator - a triple chamber rate adaptive icd, with is4 port connecting a quadripolar lv lead, home monitoring functions, max. shock of 40j and df4/is4/is-1 connector. biocompatible titanium housing is hermetically sealed and serves as a potential antipole during shock delivery or in the case of unipolar lead configuration. ellipsoid shape facilitates implanting in the pectoral muscle area. connections for bipolar pacing, sensing, unipolar connections and shock delivery are in the header. mr conditional. rivacor 7 hf-t qp belongs to a family of implantable cardioverter-defibrillators (icds). the primary objective of the therapy is to prevent sudden cardiac death. furthermore, the device is capable of treating bradycardia arrhythmias and cardiac resynchronization therapy with multisite ventricular pacing. the implantation of an icd is a symptomatic therapy with the following objectives: ?termination of spontaneous ventricular fibrillation (vf) through shock delivery ?termination of spontaneous ventricular tachycardia (vt

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - dextrose (unii: iy9xdz35w2) (dextrose - unii:iy9xdz35w2), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b), sodium acetate (unii: 4550k0sc9b) (acetic acid - unii:q40q9n063p), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838) - dextrose 5 g in 100 ml - this solution is indicated for use in adults as a source of electrolytes, calories and water for hydration, and as an alkalinizing agent. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - dextrose (unii: iy9xdz35w2) (dextrose - unii:iy9xdz35w2), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - dextrose 5 g in 100 ml - these intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories and water for hydration. these solutions are contraindicated where the administration of sodium, potassium or chloride could be clinically detrimental. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - 0.9% sodium chloride injection usp is indicated as pharmaceutic aid and diluent for the infusion of compatible drug additives. refer to prescribing information accompanying additive drugs. this solution is contraindicated where the administration of sodium or chloride could be clinically detrimental.